Shhh! 7 Small-Cap Stocks That Can Double by 2025

04:30pm, Wednesday, 20'th Mar 2024
Small cap stocks like those discussed below tend to receive much less attention than their large cap competitors. Shares, which boast a market capitalization between $250 million and $2 billion, remai
Product innovations and strategic progress bode well for Tandem Diabetes (TNDM).
Tandem Diabetes Care, Inc. (TNDM) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in

Why Tandem Diabetes Care Stock Popped Today

06:55pm, Thursday, 22'nd Feb 2024
Tandem Diabetes delivered weaker-than-expected Q4 results but followed with strong forward guidance. The company launched four new products in the U.S. last quarter.
Tandem Diabetes (TNDM) reports a higher-than-expected loss in the fourth quarter of 2023.
Tandem Diabetes Care, Inc. (TNDM) Q4 2023 Earnings Call Transcript
Although the revenue and EPS for Tandem Diabetes Care, Inc. (TNDM) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics com
Tandem Diabetes Care, Inc. (TNDM) came out with a quarterly loss of $0.27 per share versus the Zacks Consensus Estimate of a loss of $0.23. This compares to loss of $0.01 per share a year ago.
Tandem's (TNDM) Mobi is claimed to be the world's smallest durable automated insulin delivery system.
Tandem Diabetes Care, Inc. (TNDM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
SAN DIEGO--(BUSINESS WIRE)-- #TandemDiabetes--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a comp

2 Beaten-Down Stocks That Are Worth Buying

07:30am, Sunday, 04'th Feb 2024
Not every company has kept pace with the rising market, but some laggards could prove winners. Tandem Diabetes Care's innovative devices and long runway for growth should help turn things around.
SAN DIEGO--(BUSINESS WIRE)-- #TandemDiabetes--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its fourth quarter and full year 2
Tandem Diabetes' (TNDM) t:slim X2 is the first AID system to be integrated with Abbott's Freestyle Libre 2 Plus sensor.
Matthew Taylor, senior analyst at Jefferies, joins 'The Exchange' to discuss the outlook for the med tech market, his top picks for 2024, and more.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE